Startup based in the United Kingdom, 1 tracked investor.
Centessa Pharmaceuticals is a company founded in 2020 headquartered in the United Kingdom. Brouky records 1 investor associated with the company.
Centessa Pharmaceuticals is a UK-based biotechnology company that discovers and develops medicines. Its pipeline includes orexin receptor 2 (OX2R) agonists for sleep-wake disorders (such as narcolepsy and idiopathic hypersomnia) and a proprietary LockBody antibody technology aimed at cancer therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.